Pfizer and BioNTech have begun rolling submission
Pfizer and BioNTech have begun a rolling submission of their vaccine candidate to the European Medicines Agency (EMA). AstraZeneca has also begun a rolling review process. The rolling submission allows regulators to evaluate data as it becomes available, which can decrease the time it takes to decide on an approval once the final submission is made. Each cycle of the EMA’s rolling review typically takes two weeks and the duration of the review of the final application will depend on how much data was evaluated during the rolling process.anonymous Coronavirus October 07, 2020 at 10:18 am 0 0
Post a Comment
Search Thoughts
Biotech Categories
Recent Tags
biotech experts cdots nanoparticle pfizer vaccine pfizer biontech vaccine moderna leronlimab cytodyn covid-19 sinovac covid19 vaccine covid-19 coronavirus covid19 clinicaltrial coronavirus vaccine who coronavirus vaccine vaccine novavax covid19 dna vaccine rna biontech
Other sites:Executive Dating
Stupid Coworkers
Business Blog
Good News Network
Coupon Codes
Thought Tags
Get Social and Share